SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 46 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $272,000 | -0.7% | 377,244 | 0.0% | 0.03% | +13.3% |
| Q2 2019 | $274,000 | -40.2% | 377,244 | 0.0% | 0.03% | -44.4% |
| Q1 2019 | $458,000 | +191.7% | 377,244 | 0.0% | 0.05% | +200.0% |
| Q4 2018 | $157,000 | -81.6% | 377,244 | -11.8% | 0.02% | -79.1% |
| Q3 2018 | $855,000 | -5.7% | 427,642 | 0.0% | 0.09% | -7.5% |
| Q2 2018 | $907,000 | -25.9% | 427,642 | -5.0% | 0.09% | -38.4% |
| Q1 2018 | $1,224,000 | -26.3% | 450,100 | 0.0% | 0.15% | -32.6% |
| Q4 2017 | $1,661,000 | – | 450,100 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,133,583 | $4,104,000 | 3.61% |
| GREAT POINT PARTNERS LLC | 1,537,873 | $5,567,000 | 1.14% |
| BVF INC/IL | 1,392,720 | $5,042,000 | 1.01% |
| Boxer Capital, LLC | 525,000 | $1,901,000 | 0.74% |
| Vivo Capital, LLC | 500,000 | $1,810,000 | 0.60% |
| Healthcare Value Capital, LLC | 150,000 | $543,000 | 0.58% |
| Cormorant Asset Management, LP | 1,000,000 | $3,620,000 | 0.49% |
| Telemetry Investments, L.L.C. | 120,807 | $437,000 | 0.25% |
| Palo Alto Investors LP | 1,162,473 | $4,208,000 | 0.24% |
| NEA Management Company, LLC | 1,298,274 | $4,700,000 | 0.19% |